Progression of diabetic retinopathy after pancreas transplantation. The University of Michigan Pancreas Transplant Evaluation Committee.
The progression of diabetic retinopathy after combined pancreatic and kidney transplantation was studied in eight patients for 12 to 49 months. Four patients who had rapid pancreatic graft failure constituted a control group for comparison with four patients who retained functioning grafts. Using Fisher's exact probability test, the authors found no posttransplantation difference between the two groups in visual acuity lost, severity of diabetic macular edema, extent of capillary closure, progression of preretinal gliosis, development of disc or preretinal neovascularization, or worsening of the severity of the retinopathy. Achievement of normoglycemia by pancreatic transplantation is not effective in halting the progression of diabetic retinopathy in patients who already have severe diabetic microangiopathy joined the current follow-up.
Petersen
M R
MR
W. K. Kellogg Eye Center, University of Michigan, Ann Arbor 48105.
Vine
A K
AK
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000503:physiopathology*; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006442:Glycated Hemoglobin / Q000378:metabolism; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D016035:Pancreas Transplantation; D011379:Prognosis; D014792:Visual Acuity
D001786:Blood Glucose; D006442:Glycated Hemoglobin